MARKET

TXMD

TXMD

Therapeuticsmd Inc
NASDAQ
1.630
-0.010
-0.61%
After Hours: 1.581 -0.049 -2.99% 19:59 12/31 EST
OPEN
1.670
PREV CLOSE
1.640
HIGH
1.690
LOW
1.600
VOLUME
68.91K
TURNOVER
--
52 WEEK HIGH
2.440
52 WEEK LOW
0.7000
MARKET CAP
18.87M
P/E (TTM)
62.45
1D
5D
1M
3M
1Y
5Y
1D
TherapeuticsMD Inc. Stock Falls 2.4%, Underperforms Market
Dow Jones · 12/30/2025 21:34
TherapeuticsMD Insider Makes Bold Move With New Stock Purchase
TipRanks · 12/30/2025 02:05
TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market
Dow Jones · 12/29/2025 21:34
TherapeuticsMD Director Tommy G. Thompson Reports Acquisition of Common Shares
Reuters · 12/29/2025 21:24
Weekly Report: what happened at TXMD last week (1222-1226)?
Weekly Report · 12/29/2025 10:06
TherapeuticsMD Inc. Stock Rallies 2.4%, Outperforms Market
Dow Jones · 12/26/2025 21:34
TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market
Dow Jones · 12/24/2025 21:32
TherapeuticsMD Inc. Stock Sheds 2.4%, Underperforms Market
Dow Jones · 12/23/2025 21:35
More
About TXMD
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

Webull offers TherapeuticsMD Inc stock information, including NASDAQ: TXMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TXMD stock methods without spending real money on the virtual paper trading platform.